An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Acacia Research Corporation (NASDAQ: ACTG) will release its second quarter financial results on August 3, 2023. A conference call will be held to discuss the results.
Positive
The release of the second quarter financial results could positively impact the stock price if the results exceed market expectations.
Negative
There is no negative take available at the moment.
NEW YORK--(BUSINESS WIRE)--
Acacia Research Corporation (NASDAQ: ACTG) announced today it will release its second quarter financial results after the market closes on Thursday, August 3, 2023.
The Company will host a conference call on the same day to discuss these results at 4:30 p.m. ET/ 1:30 p.m. PT.
To access the live call, please dial 888-506-0062 (U.S. and Canada) or 973-528-0011 (international) and if requested, enter participant access code: 435061. The conference call will also be simultaneously webcasted on the investor relations section of the Company’s website at http://acaciaresearch.com under Events & Presentations. Following the conclusion of the live call, a replay of the webcast will be available on the Company's website for at least 30 days.
About Acacia Research Corporation
Acacia Research (NASDAQ: ACTG) acquires undervalued businesses and pursues opportunities for value creation. We leverage our (i) access to flexible capital that can be deployed unconditionally, (ii) expertise in corporate governance and operational restructuring, (iii) willingness to invest in out of favor industries and businesses that suffer from a complexity discount and untangle complex, multi-factor situations, and (iv) expertise and relationships in certain sectors, to complete strategic acquisitions of businesses, divisions, and/or assets with a focus on mature technology, healthcare, industrial and certain financial segments. We seek to identify opportunities where we believe we are advantaged buyers, where we can avoid structured sale processes and create the opportunity to purchase businesses, divisions and/or assets of companies at an attractive price due to our unique capabilities, relationships, or expertise, or where we believe the target would be worth more to us than to other buyers. Information about Acacia Research Corporation and its subsidiaries is available at www.acaciaresearch.com.
Acacia Research Investor Contact:
FNK IR
Rob Fink, 646-809-4048
rob@fnkir.com
Source: Acacia Research Corporation
FAQ
When will Acacia Research Corporation release its second quarter financial results?
Acacia Research Corporation will release its second quarter financial results on August 3, 2023.
What will happen after the release of the financial results?
A conference call will be held to discuss the results.
How can I access the conference call?
To access the live call, please dial 888-506-0062 (U.S. and Canada) or 973-528-0011 (international) and if requested, enter participant access code: 435061.
Will there be a replay of the webcast available?
Yes, a replay of the webcast will be available on the Company's website for at least 30 days.
acacia research corporation (nasdaq: actg) is the industry leader in patent licensing. by partnering with patent owners, acacia applies its deep legal and technology expertise to patent assets to unlock financial value. an intermediary in the patent market, acacia facilitates efficiency and delivers monetary rewards to the patent owner. with this strategy, acacia has generated over $1,200,000,000 revenue to date, and has returned more than $705,000,000 to our patent partners.
